{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458636272
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = o
| target = [[CD5 (protein)|CD5]]
<!-- Clinical data -->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 141483-72-9
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06381
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}
'''Zolimomab aritox''' is a mouse [[monoclonal antibody]] which has been investigated for the treatment of [[systemic lupus erythematosus]]<ref>{{cite journal|pmid=7532717|year=1994|last1=Stafford|first1=FJ|last2=Fleisher|first2=TA|last3=Lee|first3=G|last4=Brown|first4=M|last5=Strand|first5=V|last6=Austin Ha|first6=3rd|last7=Balow|first7=JE|last8=Klippel|first8=JH|title=A pilot study of anti-CD5 ricin a chain immunoconjugate in systemic lupus erythematosus|volume=21|issue=11|pages=2068–70|journal=The Journal of rheumatology}}</ref> and [[graft-versus-host disease]],<ref>{{cite journal|pmid=7584486|year=1994|last1=Przepiorka|first1=D|last2=Lemaistre|first2=CF|last3=Huh|first3=YO|last4=Luna|first4=M|last5=Saria|first5=EA|last6=Brown|first6=CT|last7=Champlin|first7=RE|title=Evaluation of anti-CD5 ricin a chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation|volume=1|issue=2|pages=77–82|journal=Therapeutic immunology}}</ref> but the studies failed to show positive effects of the drug.

It is an anti-[[CD5 (protein)|CD5]] antibody which is linked to the A chain of the [[ricin]] protein (which is reflected by the ''aritox'' in the drug's name).<ref>[http://apps.who.int/medicinedocs/index/assoc/s14171e/s14171e.pdf WHO Drug Information]</ref>
==See also==
* [[Telimomab aritox]]

==References==
{{reflist}}

{{immunosuppressants}}
{{Monoclonals for immune system}}

[[Category:Monoclonal antibodies]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}